Clinical Trial Update: A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Fadraciclib (CYC065) in advanced solid tumors and lymphoma (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• Fadraciclib (Fadraciclib)

Snippet

Sponsor: Cyclacel Pharmaceuticals, Inc. | Conditions: Solid Tumor, Adult, Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN